| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Cambrian Bio | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $284.97M | Series D | 6/29/2026 | $95.82M | $357.87M | $2.00 | Undisclosed Investors | ||||
 | Emerald Cloud Lab | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $151.12M | New Series C-1 | 7/25/2025 | $65M | $335.94M | $0.51 | Undisclosed Investors | ||||
 | Feastables | Foodtech Food Products & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $130M | Series B | 5/4/2026 | $65M | $90.86M | $1.82 | Undisclosed Investors | ||||
 | HeyGen | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $74.65M | Series A | 6/20/2024 | $60M | $477.39M | $16.21 | Benchmark, Thrive Capital, BOND, Conviction, Dylan Field, Elad Gil, Aviv Nevo, Neil Mehta, SV Angel | ||||
 | Levels | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $365.48M | Series A-1 | 4/20/2022 | $46.01M | $311.7M | $10.44 | Andrea Funsten, Ben Gilbert, David Rosenthal, Lenny Rachitsky, Mario Gabriele, Mat Fraser, Moshe Lifschitz, Niv Dror, Andreessen Horowitz, Trust Ventures, Shrug Capital, TriplePoint Capital, Long Journey Ventures | ||||
 | Lob | Industrial Logistics | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $82.21M | Series C | 2/25/2021 | $50M | $385.02M | $14.92 | Y Combinator, Indicator Ventures, Frontline Ventures | ||||
 | MBX Biosciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $216.64M | Series C | 8/5/2024 | $63.5M | $316.71M | $1.03 | Deep Track Capital, Driehaus Capital Management, T. Rowe Price Associates, Frazier Life Sciences, OrbiMed, Wellington Management | ||||
 | Vulcan Elements | Industrial Materials | Medium | $xx.xx | $xx.xx | $xx.xx | xx% | $104.50K | -- | 1 | -- | $92.63 | -0.85% | +705.48% | $73.9M | Series A-1 | 8/11/2025 | $65M | $205.83M | $11.50 | Altimeter Capital, One Investment Management, 1789 Capital, Ibex Investors, nvp capital, Washington Harbour Partners | ||||
 | Deep Infra | Enterprise Software Cloud / Networking Infrastructure | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $98.56M | Series B | 5/4/2026 | $71.5M | $262.89M | $12.45 | 500 Global, Georges Harik, A.Capital, Crescent Cove, Felicis, NVIDIA, Peak6, Samsung Next, Supermicro, Upper90, BrightCap Ventures, Chamaeleon, Justin Kan, Lukas Biewald, Mitesh Agrawal, Silkroad Innovation Hub, Symphony Ventures | ||||
 | Evommune | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $268.46M | Series C | 10/31/2024 | $115.5M | $346.35M | $1.59 | RA Capital Management, Sectoral Asset Management, B Capital, Marshall Wace, Avego Bioscience Capital, Longwood Fund, RTW Investments, ADAR1 Capital Management, NEXTBio Capital, Beiersdorf Venture Capital, FemHealth Ventures, Allostery Investments LP, Pivotal bioVenture Partners, EQT Life Sciences, Andera Partners, Amplitude Ventures, SymBiosis, Verition Fund Management | ||||
 | Volantis | Industrial Other Industrial | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $120.00K | -- | 1 | -- | Not available | -- | -- | $99.1M | Series A-1 | 7/7/2026 | $15M | $357.49M | $4.03 | Undisclosed Investors | ||||
 | Albert Invent | Enterprise Software Data Management / Storage | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $104.24M | Series B | 6/22/2026 | $55M | $342.81M | $14.75 | Undisclosed Investors | ||||
 | Browserbase | Enterprise Software Software Development | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $67.91M | Series B | 6/17/2025 | $40M | $300M | $12.73 | Notable Capital, CRV, Kleiner Perkins | ||||
 | Carbon | Industrial Manufacturing | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $740.79M | Series Prime | 11/12/2025 | $60M | $285.85M | $2.02 | Sequoia Capital, Silver Lake Technology Management, Adidas Ventures, Baillie Gifford, Madrone Capital Partners, Northgate Capital | ||||
 | Cotopaxi | Consumer & Lifestyle Clothing, Fashion, Beauty & Apparel | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $78.37M | Series C-2 | 5/22/2025 | $6.19M | $367.08M | $65.38 | Undisclosed Investors | ||||
 | Lycia Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $278.31M | Series D | 6/10/2026 | $75M | $389.03M | $2.04 | Janus Henderson Investors, Balyasny Asset Management, Adage Capital Management, HBM Healthcare Investments, OrbiMed, Eli Lilly and Company, Franklin Templeton, Invus, RTW Investments, Venrock | ||||
 | Pelage | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $150.00K | -- | 1 | -- | Not available | -- | -- | $150.75M | Series B | 10/15/2025 | $120M | $314.7M | $7.23 | ARCH Venture Partners, GV, Main Street Advisors, Visionary Ventures, YK Bioventures | ||||
 | Pendulum Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $121.76M | Series C | 6/30/2023 | $64M | $308.05M | $3.24 | Meritech Capital, Sequoia Capital, True Ventures, Khosla Ventures, Fonterra | ||||
 | Pika | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $137.09M | Series B | 6/5/2024 | $80M | $465.48M | $19.89 | Spark Capital, Greycroft, Lightspeed Venture Partners, Neo, Makers Fund, Jared Leto, Craig Kallman, Nat Friedman, Daniel Gross, Elad Gil, Adam D�Angelo, Mike Vernal, Karim Atiyeh, Aaron Levie, Andrej Karpathy, Aravind Srinivas, Clem Delangue, Alex Chung, Mateusz Staniszewski, Conviction, SV Angel | ||||
 | Tonal | Consumer & Lifestyle Fitness | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $36.25M | Series 1-C | 3/30/2026 | $5.5M | $442.4M | $0.36 | Undisclosed Investors | ||||
 | Zapier | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $1.52M | Series AA | 11/15/2014 | $1.52M | $13.47M | $0.25 | Bessemer Venture Partners, Draper Fisher Jurvesten, Brant Bukowsky, Brent Beshore, Kevin Hale, Michael Liou, Kim Miller, Jon Murray, Mike Stachowiak, Ben Li | ||||
 | Aiwyn | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $125.3M | Series B | 12/19/2024 | $77.29M | $459.67M | $9.23 | KKR, Bessemer Venture Partners | ||||
 | Bubble | Enterprise Software Software Development | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $77.75M | Series A-1 | 7/27/2021 | $70M | $489.38M | $29.57 | SignalFire, Third Kind Venture Capital, Neo, Insight Partners, BoxGroup, Betaworks | ||||
 | Credit Sesame | Fintech Personal Finance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $164.8M | Series H | 2/13/2026 | $27.25M | $179.95M | $3.75 | Undisclosed Investors | ||||